• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 10927766
Device Problems Break (1069); Fluid/Blood Leak (1250)
Patient Problems High Blood Pressure/ Hypertension (1908); Blood Loss (2597)
Event Date 11/08/2019
Event Type  malfunction  
Manufacturer Narrative
The affected product has been received and the evaluation is pending.A follow up report will be submitted once the evaluation is completed.
 
Event Description
It was reported that 3:00 am the rn initiated a labetalol infusion at a rate of 30 ml/hr.And (vtbi) volume to be infused of 100 ml.Between 3:00 ¿ 3:30 am the patient called the rn to the room to report that something was wet on his arm.Upon observation, it was found that the labetalol was piggy backed into the iv port and the white cap had popped off the injection port, but the blue part remained in the tubing.The patient bled approximately 200-300 ml of blood onto the floor.This tubing malfunction caused an interruption in the medication administration and the patient bleeding from the site caused a drop in hgb by 1 point as well as the patient's blood pressure increased by 27 points.This resulted in increased monitoring of the patient.
 
Event Description
It was reported that at 3:00am the rn initiated a labetalol infusion at a rate of 30ml/hr., and a (vtbi) volume to be infused of 100ml.Between 3:00am and 3:30am, the patient called the rn to the room to report that something was wet on his arm.Upon observation, it was found that the labetalol was piggy backed into the iv port and the white cap had popped off the injection port, but the blue part remained in the tubing.The patient bled approximately 200ml - 300ml of blood onto the floor.This tubing malfunction caused an interruption in the medication administration and the patient bleeding from the site caused a drop in hgb by (1) point as well as the patient's blood pressure increased by (27) points.This resulted in increased monitoring of the patient.
 
Manufacturer Narrative
The customer¿s report that the white cap (fla) had popped off the injection port (smartsite) was confirmed.The set was visually inspected for kinks, holes/tears in the tubing or damages to the components.Visual inspection observed that the primary set¿s distal smartsite was broken in half where the white female luer adapter (fla) meets the transparent plastic body of the smartsite.Inspection underneath a lab microscope observed white stress marks at the break site of the fla and the transparent plastic body of the smartsite.No tool marks or other anomalies were observed throughout the set.Functional testing could not be conducted due to the break on the smartsite and an obvious leak would occur.Although the root cause could not be definitively determined, the probable root cause of the smartsite break is excessive force being applied to the smartsite as indicated by the observed stress marks.
 
Event Description
It was reported that at 3:00am the rn initiated a labetalol infusion at a rate of 30ml/hr., and a (vtbi) volume to be infused of 100ml.Between 3:00am and 3:30am, the patient called the rn to the room to report that something was wet on his arm.Upon observation, it was found that the labetalol was piggy backed into the iv port and the white cap had popped off the injection port, but the blue part remained in the tubing.The patient bled approximately 200ml - 300ml of blood onto the floor.This tubing malfunction caused an interruption in the medication administration and the patient bleeding from the site caused a drop in hgb by (1) point as well as the patient's blood pressure increased by (27) points.This resulted in increased monitoring of the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS® PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key9410415
MDR Text Key169063903
Report Number9616066-2019-03541
Device Sequence Number1
Product Code FPA
UDI-Device Identifier07613203019101
UDI-Public7613203019101
Combination Product (y/n)N
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup,Followup
Report Date 11/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/18/2022
Device Model Number10927766
Device Catalogue Number10927766
Device Lot Number19096212
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/03/2019
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/04/2019
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received01/06/2020
01/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
Patient Weight114
-
-